This study aims to systematically explore the effects of psilocybin over a range of very low dose.
The study is being conducted by Diamond Therapeutics and BioPharma Services.
Trial Details
Trial Number
Data attribution
A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.
